FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

9547611000001107: Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31115301000001117 Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
31115401000001113 Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Is a Clarithromycin 125mg/5ml oral suspension 70 ml true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Is pack of Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has AMP Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Sandoz Ltd) 70 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start